Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686.
作者信息
Dhatariya Ketan
机构信息
Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, U.K.
出版信息
Diabetes Care. 2016 Jan;39(1):e18. doi: 10.2337/dc15-1956.
PMID:26696665
Abstract
摘要
相似文献
1
Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686.
Diabetes Care. 2016 Jan;39(1):e18. doi: 10.2337/dc15-1956.
2
Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686.
Diabetes Care. 2015 Nov;38(11):e198. doi: 10.2337/dc15-1700.
3
Response to Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686.
Diabetes Care. 2016 Jan;39(1):e19. doi: 10.2337/dci15-0026.
4
Diabetic ketoacidosis associated to canagliflozin in type 2 diabetes.
Med Clin (Barc). 2017 Feb 23;148(4):e19-e20. doi: 10.1016/j.medcli.2016.11.016. Epub 2016 Dec 29.
5
Euglycemic diabetic ketoacidosis with canagliflozin: Not-so-sweet but avoidable complication of sodium-glucose cotransporter-2 inhibitor use.
Can Fam Physician. 2016 Sep;62(9):725-8.
6
Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program.
Diabetes Care. 2015 Sep;38(9):1680-6. doi: 10.2337/dc15-1251. Epub 2015 Jul 22.
7
Gliflozins: ketoacidosis.
Prescrire Int. 2016 Mar;25(169):68.
8
Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin.
Intern Med. 2017;56(2):187-190. doi: 10.2169/internalmedicine.56.7501. Epub 2017 Jan 15.
9
Sodium-glucose Cotransporter 2 Inhibitor-induced Diabetic Ketoacidosis in a Type 2 Diabetic Patient.
Am J Med Sci. 2016 Jun;351(6):634-5. doi: 10.1016/j.amjms.2016.03.014. Epub 2016 Mar 31.
10
Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor.
Can Fam Physician. 2016 Sep;62(9):722-4.
引用本文的文献
1
Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.
Diabetes Metab Res Rev. 2017 Nov;33(8). doi: 10.1002/dmrr.2924. Epub 2017 Sep 29.
Zotero 插件